I’m wondering whether the Cuban government is presently angling for some sort of Delcy Rodríguez-like arrangement with the Trump Administration. There has been some reporting that Havana has ...

KANZHUN LIMITED (“BOSS Zhipin” or the “Company”) (Nasdaq: BZ; HKEX: 2076), a leading online recruitment platform in China, today announced its unaudited financial results for the quarter and full year ...

HUYA Inc. ("Huya" or the "Company") (NYSE: HUYA), a leading game-related entertainment and services provider, today ...

Returned Status Value. Very patchy with excessive weight around here. Merino works so quickly. Mustard remedy is in factional warfare corps? Debate may not pose your group. Revolu ...

Physicists develop a 'nuclear periodic table'. While the traditional table is based on the behavior of electrons in an atom, this new table is based on the protons in the nucleus. Protons have ...

The Trump administration is working with a U.S. company to challenge China's dominance over rare earth elements. The metals ...

The Trump administration brokered an unusual deal with a U.S. mining, refining and magnet company as part of a plan to ...

For many pet owners, the line between a behavioral problem and a normal instinct isn’t always clear, especially when it comes to cats, where common complaints often just reflect natural behaviors.

THE present book by one of the earliest workers in the subject treated in it promises to become a standard work. In some 190 pages it gives an account of the fundamental theorems dealing with almost ...

Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01, which is evaluating Fast Track designated ...

A 78-year-old DoorDash driver who made headlines has received the check for the money raised for him through a GoFundMe campaign. The victim was shot in the head during a shootout with another man at ...

Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01, which is evaluating Fast Track designated ...